SLRX - Sky's the limit (550% potential upside) SLRX has formed a perfect bottoming pattern on the weekly chart. Technical reasons for the trade: → Double bottom (and another smaller double bottom recently!) → Highest weekly volume ever → Break above the POC → Price still trading within the reload zone (0.618 fib) → Weekly price gaps above ma SLRX has formed a perfect bottoming ...Salarius Pharmaceuticals Inc (SLRX) Stock Price & News - Google Finance Home SLRX • NASDAQ Salarius Pharmaceuticals Inc Follow Share $0.85 Sep 8, 8:30:00 PM GMT-4 · USD · NASDAQ · Disclaimer...Salarius Pharmaceuticals' stock was trading at $1.53 at the beginning of the year. Since then, SLRX shares have decreased by 43.1% and is now trading at $0.87. View the best growth stocks for 2023 here.Salarius Pharmaceuticals Inc. Institutional investors purchased a net $118.1 thousand shares of SLRX during the quarter ended June 2019 and now own 6.43% of the total shares outstanding. This is a ...SLRX - Sky's the limit (550% potential upside) SLRX has formed a perfect bottoming pattern on the weekly chart. Technical reasons for the trade: → Double bottom (and another smaller double bottom recently!) → Highest weekly volume ever → Break above the POC → Price still trading within the reload zone (0.618 fib) → Weekly price gaps above ma SLRX has formed a perfect bottoming ...The average price target is $4.4, which means analysts expect the stock to add by 323.08% over the next twelve months. That average ranking earns Salarius Pharmaceuticals Inc an Analyst Rating of 79, which is better than 79% of stocks based on data compiled by InvestorsObserver .Jan 20, 2023 · SLRX Stock Message Board for Investors. Salarius Pharmaceuticals, Inc. Stock Price, News and Company Updates. Message Board Total Posts: 26 R. +0.26%. The Dow Jones Transportation Average DJT, -1.27% is rallying Thursday, even as most of its components are falling, as the economically sensitive index is defying the selloff in the ...Salarius (SLRX) delivered earnings and revenue surprises of 11.11% and -100.00%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?To contextualize these metrics, consider that out of all US stocks, SALARIUS PHARMACEUTICALS INC's number of analysts covering the stock is higher than 6.16% of them. SLRX has a higher upside potential (average analyst target price relative to current price) than 760.24% of all US stocks.Salarius Pharmaceuticals Inc ( SLRX) is up 10.89% today. SLRX has an Overall Score of 81. Find out what this means to you and get the rest of the rankings on SLRX! SLRX stock closed at $3.58 and is up $0.39 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between ...Salarius Pharmaceuticals Inc (SLRX) stock is trading at $1.89 as of 11:48 AM on Tuesday, May 9, a loss of -$0.28, or -12.73% from the previous closing price of $2.16. Volume today is high. So far 3,032,115 shares have traded compared to average volume of 53,027 shares. The stock has traded between $1.77 and $2.31 so far today.The Salarius Pharmaceuticals Inc. stock price gained 0.580% on the last trading day (Friday, 1st Sep 2023), rising from $0.88 to $0.89. During the last trading day the stock fluctuated 5.36% from a day low at $0.84 to a day high of $0.89. The price has risen in 5 of the last 10 days but is still down by -1.67% for this period.Find the latest Salarius Pharmaceuticals, Inc. SLRX analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Date Range. investment rating ... May 9, 2023 · Salarius Pharmaceuticals Inc (SLRX) stock is trading at $1.89 as of 11:48 AM on Tuesday, May 9, a loss of -$0.28, or -12.73% from the previous closing price of $2.16. Volume today is high. So far 3,032,115 shares have traded compared to average volume of 53,027 shares. The stock has traded between $1.77 and $2.31 so far today. Salarius Pharmaceuticals Inc. 2450 Holcombe Boulevard. Suite J-608. Houston, Texas 77021. Phone 1 346 770-0346. Industry Pharmaceuticals. Sector Health Care/Life Sciences.Short selling SLRX is an investing strategy that aims to generate trading profit from Salarius Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. youtube app download for pccomquest Aug 8, 2022 · What's Happening With SLRX Stock Today? To see InvestorsObserver's Sentiment Score for Salarius Pharmaceuticals Inc click here. More About Salarius Pharmaceuticals Inc Salarius Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing potential new cancer medicines for patients in need of new treatment options. SLRX's dividend yield, history, payout ratio, proprietary DARS™ rating & much more! Dividend.com: The #1 Source For Dividend Investing. HOUSTON, Jan. 19, 2023 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX), a clinical-stage biopharmaceutical company using protein inhibition and protein degradation to develop ...Salarius Pharmaceuticals, Inc. Common Stock (SLRX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.37. See SLRX Report. Salarius Pharmaceuticals Inc ( SLRX) is near the top in its sector according to InvestorsObserver . SLRX gets an overall rating of 51. That means it scores higher than 51% of stocks. Salarius Pharmaceuticals Inc gets a 72 rank in the Healthcare sector. Healthcare is number 4 out of 11 sectors. SLRX has an Overall Score of 51.Salarius Pharmaceuticals Inc. Institutional investors purchased a net $118.1 thousand shares of SLRX during the quarter ended June 2019 and now own 6.43% of the total shares outstanding. This is a ...SLRX gets a Bullish score from InvestorsObserver's Stock Sentiment Indicator. Salarius Pharmaceuticals Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on SLRX!Salarius Pharmaceuticals Announces Closing of $6 Million Private Placement Priced At-the-Market Under Nasdaq Rules Globe Newswire • 4 months ago. HOUSTON, May 16, 2023 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX), a clinical-stage biopharmaceutical company using protein inhibition and protein degradation to develop cancer ...SLRX Nasdaq Stock Market • delayed by 15 minutes • CURRENCY IN USD • Biotechnology & Medical Research. SALARIUS PHARMACEUTICALS, INC. SALARIUS PHARMACEUTICALS, ... Salarius Pharmaceuticals shares outstanding from 2015 to 2023. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.Find real-time SLRX - Salarius Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business.Salarius Pharmaceuticals Inc (SLRX) stock is trading at $1.89 as of 11:48 AM on Tuesday, May 9, a loss of -$0.28, or -12.73% from the previous closing price of $2.16. Volume today is high. So far 3,032,115 shares have traded compared to average volume of 53,027 shares. The stock has traded between $1.77 and $2.31 so far today.Track Exela Technologies Inc (XELA) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors zulu to english Salarius Pharmaceuticals Announces Closing of $6 Million Private Placement Priced At-the-Market Under Nasdaq Rules Globe Newswire • 4 months ago. HOUSTON, May 16, 2023 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX), a clinical-stage biopharmaceutical company using protein inhibition and protein degradation to develop cancer ...Nasdaq Russell 2000 -4.21(-0.23%) Crude Oil Gold Salarius Pharmaceuticals, Inc. (SLRX) NasdaqCM - NasdaqCM Real Time Price. Currency in USD Follow 2W 10W 9M 0.8500 -0.0200 (-2.30%) At close:...Sep 8, 2023 · finance.yahoo.com - October 18 at 10:02 AM. Salarius Pharmaceuticals, Inc.: Salarius Pharmaceuticals Announces 1-for-25 Reverse Stock Split. finanznachrichten.de - October 17 at 6:49 PM. Salarius Pharmaceuticals attempts to regain Nasdaq compliance with reverse stock split. bizjournals.com - October 14 at 3:29 PM. Salarius Pharmaceuticals Inc (SLRX) stock is trading at $2.58 as of 3:43 PM on Tuesday, Jan 31, an increase of $0.13, or 5.31% from the previous closing price of $2.45. The stock has traded between $2.43 and $2.75 so far today. Volume today is less active than usual. So far 104,998 shares have traded compared to average volume of 340,312 shares.60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share.SLRX Nasdaq Stock Market • delayed by 15 minutes • CURRENCY IN USD • Biotechnology & Medical Research. SALARIUS PHARMACEUTICALS, INC. SALARIUS PHARMACEUTICALS, ...Aug 10, 2023 · On August 10, 2023, SLRX’s average trading volume was 112.30K shares. SLRX) stock’s latest price update. The stock of Salarius Pharmaceuticals Inc. (NASDAQ: SLRX) has decreased by -9.96 when compared to last closing price of 0.84.Despite this, the company has seen a loss of -19.71% in its stock price over the last five trading days. HOUSTON, Jan. 19, 2023 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX), a clinical-stage biopharmaceutical company using protein inhibition and protein degradation to develop ...Mar 17, 2023 · Salarius Pharmaceuticals Inc (SLRX) stock is higher by 1.47% while the S&P 500 is down -0.97% as of 12:50 PM on Friday, Mar 17. SLRX has gained $0.03 from the previous closing price of $2.04 on volume of 2,093 shares. Over the past year the S&P 500 is lower by -10.00% while SLRX is down -76.82%. Aug 30, 2023 · Complete Salarius Pharmaceuticals Inc. stock information by Barron's. View real-time SLRX stock price and news, along with industry-best analysis. grand island new york Track Exela Technologies Inc (XELA) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsAug 31, 2023 · With Salarius Pharmaceuticals stock trading at $0.87 per share, the total value of Salarius Pharmaceuticals stock (market capitalization) is $3.17M. Salarius Pharmaceuticals stock was originally listed at a price of $9,343.75 in Jan 29, 2015. If you had invested in Salarius Pharmaceuticals stock at $9,343.75, your return over the last 8 years ... Aug 30, 2023 · Complete Salarius Pharmaceuticals Inc. stock information by Barron's. View real-time SLRX stock price and news, along with industry-best analysis. Find the latest Salarius Pharmaceuticals, Inc. SLRX analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Date Range. investment rating ... Salarius Pharmaceuticals Inc (NASDAQ:SLRX) institutional ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. SLRX stock closed at $1.09 and is up $0.04 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours. SLRX has a roughly average overall score of 46 meaning the stock holds a better value than 46% of stocks at its current price.Salarius Pharmaceuticals Inc (NASDAQ:SLRX) institutional ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. Salarius Pharmaceuticals, Inc. Common Stock (SLRX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.SLRX's dividend yield, history, payout ratio, proprietary DARS™ rating & much more! Dividend.com: The #1 Source For Dividend Investing.What's Happening With SLRX Stock Today? To see InvestorsObserver's Sentiment Score for Salarius Pharmaceuticals Inc click here. More About Salarius Pharmaceuticals Inc Salarius Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing potential new cancer medicines for patients in need of new treatment options.Salarius Pharmaceuticals Inc (SLRX) Stock Price & News - Google Finance Home SLRX • NASDAQ Salarius Pharmaceuticals Inc Follow Share $0.85 Sep 8, 8:30:00 PM GMT-4 · USD · NASDAQ · Disclaimer... Aug 31, 2023 · With Salarius Pharmaceuticals stock trading at $0.87 per share, the total value of Salarius Pharmaceuticals stock (market capitalization) is $3.17M. Salarius Pharmaceuticals stock was originally listed at a price of $9,343.75 in Jan 29, 2015. If you had invested in Salarius Pharmaceuticals stock at $9,343.75, your return over the last 8 years ... Oct 14, 2022 · The reverse stock split is intended to enable Salarius to regain compliance with the $1.00 minimum closing bid price required for continued listing on the Nasdaq Capital Market. Jul 24, 2023 · Nasdaq | SLRX U.S.: Nasdaq Salarius Pharmaceuticals Inc. Watch list After Hours Last Updated: Jul 3, 2023 4:00 p.m. EDT Real time quote $ 1.5564 0.11 7.34% After Hours Volume: 11 Advanced... de luto SLRX Nasdaq Stock Market • delayed by 15 minutes • CURRENCY IN USD • Biotechnology & Medical Research. SALARIUS PHARMACEUTICALS, INC. SALARIUS PHARMACEUTICALS, ... Aug 20, 2021 · Salarius Pharmaceuticals, Inc. (SLRX) is down 8.98% in the pre-market trading session at the price of $0.82 despite any recent www. SLRX Presented at the Virtual Diamond Equity Research Emerging Growth Invitational SLRX CEO David Arthur presented virtually at the Diamond Equity Research Emerging Growth Invitational Conference on 17th August 2021. The conference details were Salarius Pharmaceuticals Inc (SLRX) Stock Price & News - Google Finance Home SLRX • NASDAQ Salarius Pharmaceuticals Inc Follow Share $0.85 Sep 8, 8:30:00 PM GMT-4 · USD · NASDAQ · Disclaimer... SLRX -9.38%. 27. See SLRX Report. InvestorsObserver is giving Salarius Pharmaceuticals Inc (SLRX) an Analyst Rating Rank of 74, meaning SLRX is ranked higher by analysts than 74% of stocks. The average price target for SLRX is $5 and analyst’s rate the stock as a Strong Buy. Wall Street analysts are rating SLRX a Strong Buy today. membersalliance credit union Salarius Pharmaceuticals, Inc. Common Stock (SLRX) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets.Nasdaq | SLRX U.S.: Nasdaq Salarius Pharmaceuticals Inc. Watch list After Hours Last Updated: Jul 3, 2023 4:00 p.m. EDT Real time quote $ 1.5564 0.11 7.34% After Hours Volume: 11 Advanced...Jan 5, 2021 · The average price target is $4.4, which means analysts expect the stock to add by 323.08% over the next twelve months. That average ranking earns Salarius Pharmaceuticals Inc an Analyst Rating of 79, which is better than 79% of stocks based on data compiled by InvestorsObserver . Salarius Pharmaceuticals Inc. analyst ratings, historical stock prices, earnings estimates & actuals. SLRX updated stock price target summary.Salarius Pharmaceuticals Inc (SLRX) Stock Price & News - Google Finance Home SLRX • NASDAQ Salarius Pharmaceuticals Inc Follow Share $0.85 Sep 8, 8:30:00 PM GMT-4 · USD · NASDAQ · Disclaimer... Track Exela Technologies Inc (XELA) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsHOUSTON, Oct. 14, 2022 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX), a clinical-stage biopharmaceutical company developing medicines for patients fighting cancer and in need of new treatment options, today announced that it will effect a 1-for-25 reverse stock split at 5:00 p.m. Eastern time today. koshalar LADENBURG THALM/SH SH cut shares of Salarius Pharmaceuticals (NASDAQ:SLRX Free Report) from a buy rating to a neutral rating in a research note released on Friday, FlyOnTheWall reports. Salarius Pharmaceuticals Trading Down 5.9 % Shares of SLRX stock opened at $0.65 on Friday. The business&#... Sep 13, 2023 · Salarius Pharmaceuticals last posted its earnings results on August 10th, 2023. The reported ($1.43) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.26) by $0.17. Salarius Pharmaceuticals has generated ($12.90) earnings per share over the last year ( ($12.90) diluted earnings per share). SLRX - Sky's the limit (550% potential upside) SLRX has formed a perfect bottoming pattern on the weekly chart. Technical reasons for the trade: → Double bottom (and another smaller double bottom recently!) → Highest weekly volume ever → Break above the POC → Price still trading within the reload zone (0.618 fib) → Weekly price gaps above ma SLRX has formed a perfect bottoming ... See Salarius Pharmaceuticals, Inc. (SLRX) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. flights to kalispell mt Salarius Pharmaceuticals Inc (SLRX) stock is higher by 1.47% while the S&P 500 is down -0.97% as of 12:50 PM on Friday, Mar 17. SLRX has gained $0.03 from the previous closing price of $2.04 on volume of 2,093 shares. Over the past year the S&P 500 is lower by -10.00% while SLRX is down -76.82%.See Salarius Pharmaceuticals, Inc. (SLRX) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. SLRX -9.38%. 27. See SLRX Report. InvestorsObserver is giving Salarius Pharmaceuticals Inc (SLRX) an Analyst Rating Rank of 74, meaning SLRX is ranked higher by analysts than 74% of stocks. The average price target for SLRX is $5 and analyst’s rate the stock as a Strong Buy. Wall Street analysts are rating SLRX a Strong Buy today. directions to ocean city maryland Dec 11, 2020 · HOUSTON, Dec. 11, 2020 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical company developing potential... Salarius Pharmaceuticals shares outstanding from 2015 to 2023. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares. The estimated Net Worth of Mark J Rosenblum is at least $572 Thousand dollars as of 31 May 2022. Mr. Rosenblum owns over 28,000 units of Salarius Pharmaceuticals stock worth over $133,487 and over the last 13 years he sold SLRX stock worth over $0.SLRX Earnings Date and Information. Salarius Pharmaceuticals last posted its earnings results on August 10th, 2023. The reported ($1.43) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.26) by $0.17.Find real-time SLRX - Salarius Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. SLRX Nasdaq Stock Market • delayed by 15 minutes • CURRENCY IN USD • Biotechnology & Medical Research. SALARIUS PHARMACEUTICALS, INC. SALARIUS PHARMACEUTICALS, ...SLRX - Sky's the limit (550% potential upside) SLRX has formed a perfect bottoming pattern on the weekly chart. Technical reasons for the trade: → Double bottom (and another smaller double bottom recently!) → Highest weekly volume ever → Break above the POC → Price still trading within the reload zone (0.618 fib) → Weekly price gaps above ma SLRX has formed a perfect bottoming ...Sep 7, 2023 · Stock analysis for Salarius Pharmaceuticals Inc (SLRX:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Salarius Pharmaceuticals to Report Fourth Quarter and Full Year 2020 Financial Results. (GlobeNewswire) +5.37%. Mar-08-21 04:05PM. Salarius Announces Closing of $23 Million Underwritten Public Offering of Common Stock Following Full Exercise of Over-Allotment Option. (GlobeNewswire) +5.47%.Salarius Pharmaceuticals Inc. Institutional investors purchased a net $118.1 thousand shares of SLRX during the quarter ended June 2019 and now own 6.43% of the total shares outstanding. This is a ...52 Week Low Date 12/27/22. Market Cap 4.344M. Shares Out 2.47M. 10 Day Average Volume 0.10M. Dividend -. Dividend Yield -. Beta 0.98. YTD % Change 15.03. Salarius Pharmaceuticals to Present SP-3164 at the 5th Annual Targeted Protein Degradation Conference. HOUSTON, Oct. 19, 2022 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX), a clinical-stage biopharmaceutical company using protein inhibition and protein degradation to develop cancer ... 11 months ago - GlobeNewsWire.Nasdaq | SLRX U.S.: Nasdaq Salarius Pharmaceuticals Inc. Watch list After Hours Last Updated: Jul 3, 2023 4:00 p.m. EDT Real time quote $ 1.5564 0.11 7.34% After Hours Volume: 11 Advanced... euro rate in pakistan Salarius Pharmaceuticals Inc. 2450 Holcombe Boulevard. Suite J-608. Houston, Texas 77021. Phone 1 346 770-0346. Industry Pharmaceuticals. Sector Health Care/Life Sciences. Jul 24, 2023 · Nasdaq | SLRX U.S.: Nasdaq Salarius Pharmaceuticals Inc. Watch list After Hours Last Updated: Jul 3, 2023 4:00 p.m. EDT Real time quote $ 1.5564 0.11 7.34% After Hours Volume: 11 Advanced... Short selling SLRX is an investing strategy that aims to generate trading profit from Salarius Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender.HOUSTON, Oct. 14, 2022 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX), a clinical-stage biopharmaceutical company developing medicines for patients fighting cancer and in need ...Salarius Pharmaceuticals Inc. analyst ratings, historical stock prices, earnings estimates & actuals. SLRX updated stock price target summary.Salarius Pharmaceuticals, Inc. Common Stock (SLRX) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets. Jun 15, 2022 · HOUSTON, Oct. 14, 2022 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX), a clinical-stage biopharmaceutical company developing medicines for patients fighting cancer and in need of new treatment options, today announced that it will effect a 1-for-25 reverse stock split at 5:00 p.m. Eastern time today. Salarius Pharmaceuticals shares outstanding from 2015 to 2023. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.Nov 4, 2021 · Salarius (SLRX) delivered earnings and revenue surprises of 11.11% and -100.00%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock? As of Jun. 30, SLRX reports $22.6M of cash, cash equivalents, and restricted cash, which it said would be adequate to fund operations into 2023, despite a potential rise of R&D expenses in 2023 ... rupar An Income Statement is a collection of records that outline the financial activities of a business, an individual or any other entity. Financial statements are meant to present the financial information of the entity in question as clearly and concisely as possible for both the entity and for readers. Financial statements for businesses usually ... HOUSTON, Dec. 11, 2020 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical company developing potential...An Income Statement is a collection of records that outline the financial activities of a business, an individual or any other entity. Financial statements are meant to present the financial information of the entity in question as clearly and concisely as possible for both the entity and for readers. Financial statements for businesses usually ...Sep 8, 2023 · The Price to Sales ratio or P/S is calculated as price divided by sales. After the P/E ratio, it's one of the most common valuation metrics. If the P/S ratio is 1, that means you're paying $1 for ... The estimated Net Worth of Jonathan I Lieber is at least $33 Thousand dollars as of 7 June 2022. Mr. Lieber owns over 37,500 units of Salarius Pharmaceuticals stock worth over $33,000 and over the last 10 years he sold SLRX stock worth over $0. In addition, he makes $0 as Independent Director at Salarius Pharmaceuticals.Sep 8, 2023 · SLRX support price is $.80 and resistance is $.94 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SLRX stock will trade within this expected range on the day. SLRX support price is $.80 and resistance is $.94 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SLRX stock will trade within this expected range on the day.SLRX gets a Bullish score from InvestorsObserver's Stock Sentiment Indicator. Salarius Pharmaceuticals Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on SLRX!Stock Price Forecast. The 2 analysts offering 12-month price forecasts for Salarius Pharmaceuticals Inc have a median target of 5.63, with a high estimate of 8.00 and a low estimate of 3.25. The ... Jan 20, 2023 · SLRX Stock Message Board for Investors. Salarius Pharmaceuticals, Inc. Stock Price, News and Company Updates. Message Board Total Posts: 26 SLRX has fallen -$0.15 from the previous closing price of $1.17 on volume of 799,590 shares. Over the past year the S&P 500 is up 16.46% while SLRX has fallen -65.19%. SLRX lost -$0.90 per share the over the last 12 months. Click Here to get the full report on Salarius Pharmaceuticals Inc (SLRX) Stock.Salarius Pharmaceuticals, Inc. Common Stock (SLRX) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets.Aug 16, 2023 · SLRX stock saw a decrease of -15.42% in the past week, with a monthly decline of -37.42% and a quarterly a decrease of -50.46%. The volatility ratio for the week is 17.08%, and the volatility levels for the last 30 days are 11.16% for Salarius Pharmaceuticals Inc. (SLRX). SLRX Earnings Date and Information. Salarius Pharmaceuticals last posted its earnings results on August 10th, 2023. The reported ($1.43) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.26) by $0.17.Sep 8, 2023 · finance.yahoo.com - October 18 at 10:02 AM. Salarius Pharmaceuticals, Inc.: Salarius Pharmaceuticals Announces 1-for-25 Reverse Stock Split. finanznachrichten.de - October 17 at 6:49 PM. Salarius Pharmaceuticals attempts to regain Nasdaq compliance with reverse stock split. bizjournals.com - October 14 at 3:29 PM. Find real-time SLRX - Salarius Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business.See Salarius Pharmaceuticals, Inc. (SLRX) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. bad neighbours Sep 8, 2023 · A stock signal may provide low statistical accuracy, but the signals may prove high return in average. Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy). Nasdaq Russell 2000 -4.21(-0.23%) Crude Oil Gold Salarius Pharmaceuticals, Inc. (SLRX) NasdaqCM - NasdaqCM Real Time Price. Currency in USD Follow 2W 10W 9M 0.8500 -0.0200 (-2.30%) At close:... Sep 11, 2023 · View Salarius Pharmaceuticals, Inc SLRX investment & stock information. Get the latest Salarius Pharmaceuticals, Inc SLRX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Salarius is the recipient of a three-year $16.1 million Cancer Prevention and Research Institute of Texas (CPRIT) New Company Product Development award. Salarius has also received financial and in-kind support from the National Pediatric Cancer Foundation. We are located in the Texas Medical Center Innovation facility in Houston, Texas. ft8 Salarius Pharmaceuticals shares outstanding from 2015 to 2023. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares. Jul 4, 2023 · SLRX stock returns are also predicted based on historical data. According to our research, SLRX stock is a bad long-term investment. SLRX share price has been in a bear cycle for the past year. Salarius Pharmaceuticals, Inc. stock trend is negative . Discover historical prices for SLRX stock on Yahoo Finance. View daily, weekly or monthly format back to when Salarius Pharmaceuticals, Inc. stock was issued.10% least volatile stocks in US Market. 2.6%. Stable Share Price: SLRX is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 12% a week. Volatility Over Time: SLRX's weekly volatility has decreased from 18% to 12% over the past year, but is still higher than 75% of US stocks.May 9, 2023 · Salarius Pharmaceuticals Inc (SLRX) stock is trading at $1.89 as of 11:48 AM on Tuesday, May 9, a loss of -$0.28, or -12.73% from the previous closing price of $2.16. Volume today is high. So far 3,032,115 shares have traded compared to average volume of 53,027 shares. The stock has traded between $1.77 and $2.31 so far today. Track Salarius Pharmaceuticals Inc (SLRX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsSalarius Pharmaceuticals Inc - SLRX stock news. Get the latest stock news for Nasdaq companies, press releases, financial disclosures and multimedia content, for day traders, investment community, individual investors and the general public.Salarius Pharmaceuticals Inc - SLRX stock news. Get the latest stock news for Nasdaq companies, press releases, financial disclosures and multimedia content, for day traders, investment community, individual investors and the general public.Sep 11, 2023 · View Salarius Pharmaceuticals, Inc SLRX investment & stock information. Get the latest Salarius Pharmaceuticals, Inc SLRX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. The Price to Sales ratio or P/S is calculated as price divided by sales. After the P/E ratio, it's one of the most common valuation metrics. If the P/S ratio is 1, that means you're paying $1 for ... ms pac man 60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share.Jun 15, 2022 · HOUSTON, Oct. 14, 2022 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX), a clinical-stage biopharmaceutical company developing medicines for patients fighting cancer and in need of new treatment options, today announced that it will effect a 1-for-25 reverse stock split at 5:00 p.m. Eastern time today. Sep 7, 2023 · Stock analysis for Salarius Pharmaceuticals Inc (SLRX:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Sep 28, 2021 · SLRX stock closed at $1.09 and is up $0.04 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours. SLRX has a roughly average overall score of 46 meaning the stock holds a better value than 46% of stocks at its current price. Salarius Pharmaceuticals Inc (SLRX) Stock Price & News - Google Finance Home SLRX • NASDAQ Salarius Pharmaceuticals Inc Follow Share $0.85 Sep 8, 8:30:00 PM GMT-4 · USD · NASDAQ · Disclaimer... journey back to christmas Dec 27, 2021 · What's Happening With SLRX Stock Today? More About Salarius Pharmaceuticals Inc Salarius Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing effective treatments for cancers with high, unmet medical need. Salarius Pharmaceuticals Inc. analyst estimates, including SLRX earnings per share estimates and analyst recommendations.HOUSTON, Oct. 14, 2022 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX), a clinical-stage biopharmaceutical company developing medicines for patients fighting cancer and in need of new treatment options, today announced that it will effect a 1-for-25 reverse stock split at 5:00 p.m. Eastern time today.The latest Salarius Pharmaceuticals stock prices, stock quotes, news, and SLRX history to help you invest and trade smarter. mac's fresh market The volatility ratio for the week is 17.08%, and the volatility levels for the last 30 days are 11.16% for Salarius Pharmaceuticals Inc. (SLRX). The simple moving average for the past 20 days is -19.67% for SLRX’s stock, with a -59.26% simple moving average for the past 200 days. Analysts’ Opinion of SLRXSalarius Pharmaceuticals Inc ( SLRX) is up 10.89% today. SLRX has an Overall Score of 81. Find out what this means to you and get the rest of the rankings on SLRX! SLRX stock closed at $3.58 and is up $0.39 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between ... dallas to mexico city Overview Key Ratios Trading Information Last Close 0.88 Sector Healthcare Industry Biotechnology Investment Style Small Value Day Range 0.85 – 0.89 Year Range 0.61 – 7.20 Market Cap 3.2041 Mil...The latest Salarius Pharmaceuticals stock prices, stock quotes, news, and SLRX history to help you invest and trade smarter.Find real-time SLRX - Salarius Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business.SLRX stock forecast Our latest prediction for Salarius Pharmaceuticals Inc's stock price was made on the Aug. 17, 2021 when the stock price was at 0.88$. In the short term (2weeks), SLRX's stock price should outperform the market by 1.74%. During that period the price should oscillate between -10.47% and +17.69%.Aug 8, 2022 · What's Happening With SLRX Stock Today? To see InvestorsObserver's Sentiment Score for Salarius Pharmaceuticals Inc click here. More About Salarius Pharmaceuticals Inc Salarius Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing potential new cancer medicines for patients in need of new treatment options. May 9, 2023 · Salarius Pharmaceuticals Inc (SLRX) stock is trading at $1.89 as of 11:48 AM on Tuesday, May 9, a loss of -$0.28, or -12.73% from the previous closing price of $2.16. Volume today is high. So far 3,032,115 shares have traded compared to average volume of 53,027 shares. The stock has traded between $1.77 and $2.31 so far today. On August 10, 2023, SLRX’s average trading volume was 112.30K shares. SLRX) stock’s latest price update. The stock of Salarius Pharmaceuticals Inc. (NASDAQ: SLRX) has decreased by -9.96 when compared to last closing price of 0.84.Despite this, the company has seen a loss of -19.71% in its stock price over the last five trading days.60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share.SLRX Nasdaq Stock Market • delayed by 15 minutes • CURRENCY IN USD • Biotechnology & Medical Research. SALARIUS PHARMACEUTICALS, INC. SALARIUS PHARMACEUTICALS, ... SLRX has fallen -$0.15 from the previous closing price of $1.17 on volume of 799,590 shares. Over the past year the S&P 500 is up 16.46% while SLRX has fallen -65.19%. SLRX lost -$0.90 per share the over the last 12 months. Click Here to get the full report on Salarius Pharmaceuticals Inc (SLRX) Stock. asheboro high school Salarius Pharmaceuticals to Present SP-3164 at the 5th Annual Targeted Protein Degradation Conference. HOUSTON, Oct. 19, 2022 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX), a clinical-stage biopharmaceutical company using protein inhibition and protein degradation to develop cancer ... 11 months ago - GlobeNewsWire.SLRX's dividend yield, history, payout ratio, proprietary DARS™ rating & much more! Dividend.com: The #1 Source For Dividend Investing. The average price target is $4.4, which means analysts expect the stock to add by 323.08% over the next twelve months. That average ranking earns Salarius Pharmaceuticals Inc an Analyst Rating of 79, which is better than 79% of stocks based on data compiled by InvestorsObserver .Salarius Pharmaceuticals, Inc. Common Stock (SLRX) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets. 1941 movie Aug 16, 2023 · SLRX stock saw a decrease of -15.42% in the past week, with a monthly decline of -37.42% and a quarterly a decrease of -50.46%. The volatility ratio for the week is 17.08%, and the volatility levels for the last 30 days are 11.16% for Salarius Pharmaceuticals Inc. (SLRX). HOUSTON, Oct. 14, 2022 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX), a clinical-stage biopharmaceutical company developing medicines for patients fighting cancer and in need ...What's Happening With SLRX Stock Today? To see InvestorsObserver's Sentiment Score for Salarius Pharmaceuticals Inc click here. More About Salarius Pharmaceuticals Inc Salarius Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing potential new cancer medicines for patients in need of new treatment options. the fresh prince of bel air season 1 2 days ago · Salarius Pharmaceuticals to Present SP-3164 at the 5th Annual Targeted Protein Degradation Conference. HOUSTON, Oct. 19, 2022 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX), a clinical-stage biopharmaceutical company using protein inhibition and protein degradation to develop cancer ... 11 months ago - GlobeNewsWire. Jan 13, 2022 · Salarius is the recipient of a three-year $16.1 million Cancer Prevention and Research Institute of Texas (CPRIT) New Company Product Development award. Salarius has also received financial and in-kind support from the National Pediatric Cancer Foundation. We are located in the Texas Medical Center Innovation facility in Houston, Texas. Salarius is the recipient of a three-year $16.1 million Cancer Prevention and Research Institute of Texas (CPRIT) New Company Product Development award. Salarius has also received financial and in-kind support from the National Pediatric Cancer Foundation. We are located in the Texas Medical Center Innovation facility in Houston, Texas.Salarius Pharmaceuticals SLRX (SLRX) Message Board - Company Name: Salarius Pharmaceuticals SLRX, Stock Symbol: SLRX, Industry: Biotechs - Total Posts: 162 - Last Post: 08/12/2023 01:49:55 PM - company/specific stock boardFind the latest Salarius Pharmaceuticals, Inc. SLRX analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Date Range. investment rating ... Sep 13, 2023 · With Salarius Pharmaceuticals stock trading at $0.89 per share, the total value of Salarius Pharmaceuticals stock (market capitalization) is $3.22M. Salarius Pharmaceuticals stock was originally listed at a price of $9,343.75 in Jan 29, 2015. If you had invested in Salarius Pharmaceuticals stock at $9,343.75, your return over the last 8 years ... Jan 20, 2023 · Salarius Pharmaceuticals Inc ( SLRX) is up 10.89% today. SLRX has an Overall Score of 81. Find out what this means to you and get the rest of the rankings on SLRX! SLRX stock closed at $3.58 and is up $0.39 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between ... Salarius Pharmaceuticals Inc (SLRX) stock is higher by 1.47% while the S&P 500 is down -0.97% as of 12:50 PM on Friday, Mar 17. SLRX has gained $0.03 from the previous closing price of $2.04 on volume of 2,093 shares. Over the past year the S&P 500 is lower by -10.00% while SLRX is down -76.82%. just serve Stock Price Forecast. The 2 analysts offering 12-month price forecasts for Salarius Pharmaceuticals Inc have a median target of 5.63, with a high estimate of 8.00 and a low estimate of 3.25. The ... SLRX stock closed at $1.09 and is up $0.04 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours. SLRX has a roughly average overall score of 46 meaning the stock holds a better value than 46% of stocks at its current price.SLRX -9.38%. 27. See SLRX Report. InvestorsObserver is giving Salarius Pharmaceuticals Inc (SLRX) an Analyst Rating Rank of 74, meaning SLRX is ranked higher by analysts than 74% of stocks. The average price target for SLRX is $5 and analyst’s rate the stock as a Strong Buy. Wall Street analysts are rating SLRX a Strong Buy today.Salarius Pharmaceuticals shares outstanding from 2015 to 2023. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares. View Salarius Pharmaceuticals, Inc SLRX investment & stock information. Get the latest Salarius Pharmaceuticals, Inc SLRX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. gay agenda Salarius Pharmaceuticals Inc. analyst ratings, historical stock prices, earnings estimates & actuals. SLRX updated stock price target summary.What's Happening With SLRX Stock Today? To see InvestorsObserver's Sentiment Score for Salarius Pharmaceuticals Inc click here. More About Salarius Pharmaceuticals Inc Salarius Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing potential new cancer medicines for patients in need of new treatment options.The reverse stock split is intended to enable Salarius to regain compliance with the $1.00 minimum closing bid price required for continued listing on the Nasdaq Capital Market.Salarius Pharmaceuticals Inc (SLRX) stock is trading at $1.89 as of 11:48 AM on Tuesday, May 9, a loss of -$0.28, or -12.73% from the previous closing price of $2.16. Volume today is high. So far 3,032,115 shares have traded compared to average volume of 53,027 shares. The stock has traded between $1.77 and $2.31 so far today.On August 10, 2023, SLRX’s average trading volume was 112.30K shares. SLRX) stock’s latest price update. The stock of Salarius Pharmaceuticals Inc. (NASDAQ: SLRX) has decreased by -9.96 when compared to last closing price of 0.84.Despite this, the company has seen a loss of -19.71% in its stock price over the last five trading days.